Clinical data | |
---|---|
Trade names | Amerge, Naramig, others |
AHFS/Drugs.com | Monograph |
MedlinePlus | a601083 |
Pregnancy category |
|
Routes of administration | By mouth |
Drug class | Triptan[1] |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | 74% |
Metabolism | Liver |
Elimination half-life | 5-8 hours |
Excretion | Kidney |
Identifiers | |
| |
Chemical and physical data | |
Formula | C17H25N3O2S |
Molar mass | 335.47 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Naratriptan, sold under the brand name Amerge among others, is a medication used to treat migraine headaches.[1] It is not used preventatively.[1] It is taken by mouth.[1]
Common side effects include numbness, nausea, sleepiness, and tiredness.[1] Other side effects may include coronary vasospasm, stroke, high blood pressure, serotonin syndrome, anaphylaxis, and medication overuse headache.[1] Safety in pregnancy is unclear.[3] It is a triptan which works as a selective 5-HT1 receptor agonist.[1]
Naratriptan was patented in 1987 and approved for medical use in 1997.[4] It is available as a generic medication.[2] In the United Kingdom 6 tablets costs the NHS about £3 as of 2021.[2] This amount in the United States is about 11 USD.[5]
References edit
- ^ a b c d e f g h i "Naratriptan Monograph for Professionals". Drugs.com. Archived from the original on 25 January 2021. Retrieved 11 November 2021.
- ^ a b c BNF 81: March-September 2021. BMJ Group and the Pharmaceutical Press. 2021. p. 501. ISBN 978-0857114105.
- ^ "Naratriptan (Amerge) Use During Pregnancy". Drugs.com. Archived from the original on 25 November 2020. Retrieved 12 November 2021.
- ^ Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 531. ISBN 978-3-527-60749-5. Archived from the original on 2020-10-23. Retrieved 2021-10-24.
- ^ "Naratriptan Prices, Coupons & Savings Tips - GoodRx". GoodRx. Archived from the original on 31 October 2016. Retrieved 11 November 2021.